Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Clariden Investment

Inactive STATUS

Clariden Investment was a venture capital firm that preferred to invest in the biotechnology sector.

Investor Status
Out of Business
Primary Investor Type
Venture Capital
Primary Office
  • Switzerland

Clariden Investment Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Santhera Pharmaceuticals 01-Oct-2006 Early Stage VC 0000 Biotechnology Generating Revenue/Not Profitable
00000000 000000000 01-Jan-2005 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable
00000 000000000000 17-Aug-2004 00000 00000 0000 Drug Delivery Profitable
00000 000000000000 25-May-2004 00000 00000 0000 Biotechnology Out of Business
00000000 30-Mar-2004 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2
Altus Pharmaceuticals 26-Dec-2001 Later Stage VC 000.00 Biotechnology Out of Business
CyDex Pharmaceuticals 11-Oct-2000 Early Stage VC 0000 Drug Delivery Profitable
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Clariden Investment’s full profile, request a free trial.

Clariden Investment Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
CyDex Pharmaceuticals 26-Jan-2011 Merger/Acquisition 000.00 Completed
00000000 000000000 03-Nov-2006 000 000.00 Completed
Altus Pharmaceuticals 26-Jan-2006 IPO 00000 Completed
Salmedix 14-Jun-2005 Merger/Acquisition 00000 Completed
To view this investor’s complete exits history, request access »